Teladoc Stock Falls Below 52-Week Lows On Q2 Earnings: Guidance Withdrawn On BetterHealth Weakness, 'Focused On Addressing The Work Ahead Of Us With Urgency'
Portfolio Pulse from Chris Katje
Teladoc Health Inc (NYSE:TDOC) reported Q2 revenue of $642.4 million, missing estimates and down 2% YoY. The company posted a loss of 28 cents per share, better than expected. Integrated Care revenue rose 5%, while BetterHealth revenue fell 9%. U.S. revenue decreased 4%, and international revenue increased 12%. Teladoc withdrew its full-year and three-year financial outlooks due to BetterHealth segment weakness. Shares fell 13% in after-hours trading.
July 31, 2024 | 8:44 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Teladoc Health reported Q2 revenue of $642.4 million, missing estimates and down 2% YoY. The company posted a loss of 28 cents per share, better than expected. Integrated Care revenue rose 5%, while BetterHealth revenue fell 9%. U.S. revenue decreased 4%, and international revenue increased 12%. Teladoc withdrew its full-year and three-year financial outlooks due to BetterHealth segment weakness. Shares fell 13% in after-hours trading.
Teladoc's Q2 revenue missed estimates and declined YoY, with significant weakness in the BetterHealth segment. The withdrawal of full-year and three-year financial outlooks indicates uncertainty and potential challenges ahead. The 13% drop in after-hours trading reflects investor concerns.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100